Shiramoto, M., Yoshihara, T., Schmider, W., Takagi, H., Nowotny, I., Kajiwara, M., & Muto, H. (2021). Pharmacokinetic and pharmacodynamic similarity between SAR341402 insulin aspart and Japan-approved NovoRapid in healthy Japanese subjects. Nature Portfolio.
Style de citation Chicago (17e éd.)Shiramoto, Masanari, Tatsuya Yoshihara, Wolfgang Schmider, Hiroki Takagi, Irene Nowotny, Miyuki Kajiwara, et Hideya Muto. Pharmacokinetic and Pharmacodynamic Similarity Between SAR341402 Insulin Aspart and Japan-approved NovoRapid in Healthy Japanese Subjects. Nature Portfolio, 2021.
Style de citation MLA (8e éd.)Shiramoto, Masanari, et al. Pharmacokinetic and Pharmacodynamic Similarity Between SAR341402 Insulin Aspart and Japan-approved NovoRapid in Healthy Japanese Subjects. Nature Portfolio, 2021.